tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BriaCell Expands Phase 3 Cancer Study with New Clinical Sites
Company AnnouncementsBriaCell Expands Phase 3 Cancer Study with New Clinical Sites
5d ago
BCTX
BriaCell announces addition of two key large cancer centers to Phase 3 study
PremiumThe Fly
BriaCell announces addition of two key large cancer centers to Phase 3 study
5d ago
BCTX
BriaCell’s Phase 3 Study in Metastatic Breast Cancer Receives Positive DSMB Recommendation
PremiumCompany Announcements
BriaCell’s Phase 3 Study in Metastatic Breast Cancer Receives Positive DSMB Recommendation
13d ago
BCTX
BriaCell reports iDSMB has completed third scheduled safety data review
PremiumThe Fly
BriaCell reports iDSMB has completed third scheduled safety data review
13d ago
BCTX
BriaCell Reports Increased Losses in Latest Financials
PremiumCompany Announcements
BriaCell Reports Increased Losses in Latest Financials
19d ago
8K
BCTX
BriaCell Therapeutics Schedules Virtual Investor Presentations for June 2025
PremiumCompany AnnouncementsBriaCell Therapeutics Schedules Virtual Investor Presentations for June 2025
1M ago
BCTX
Promising Phase 2 Results and Safety Profile Support Buy Rating for BriaCell Therapeutics
Premium
Ratings
Promising Phase 2 Results and Safety Profile Support Buy Rating for BriaCell Therapeutics
1M ago
BCTX
BriaCell Reports Promising Survival Data in Metastatic Breast Cancer Studies
Premium
Company Announcements
BriaCell Reports Promising Survival Data in Metastatic Breast Cancer Studies
1M ago
BCTX
BriaCell reports overall survival, clinical benefit data at ASCO 2025
PremiumThe Fly
BriaCell reports overall survival, clinical benefit data at ASCO 2025
1M ago
BCTX
BriaCell Advances Bria-OTS in Cancer Immunotherapy with New Study Phase
PremiumCompany Announcements
BriaCell Advances Bria-OTS in Cancer Immunotherapy with New Study Phase
1M ago
BCTX
BriaCell Bria-OTS Phase 1/2 study clears safety evaluation
PremiumThe Fly
BriaCell Bria-OTS Phase 1/2 study clears safety evaluation
1M ago
BCTX
BriaCell Therapeutics Reports Promising Phase 2 Results for Metastatic Breast Cancer Treatment
PremiumCompany Announcements
BriaCell Therapeutics Reports Promising Phase 2 Results for Metastatic Breast Cancer Treatment
1M ago
BCTX
BriaCell announces presentation of survival, clinical benefit data at ASCO 2025
PremiumThe FlyBriaCell announces presentation of survival, clinical benefit data at ASCO 2025
1M ago
BCTX
BriaCell Therapeutics Advances in Cancer Immunotherapy with Promising Clinical Results
Premium
Company Announcements
BriaCell Therapeutics Advances in Cancer Immunotherapy with Promising Clinical Results
2M ago
BCTX
BriaCell issues letter to shareholders
Premium
The Fly
BriaCell issues letter to shareholders
2M ago
BCTX
BriaCell’s Phase 3 Data Shows Promise for Metastatic Breast Cancer Treatment
PremiumCompany Announcements
BriaCell’s Phase 3 Data Shows Promise for Metastatic Breast Cancer Treatment
2M ago
BCTX
BriaCell presents preclinical data from Phase 3 study of Bria-IMT
PremiumThe Fly
BriaCell presents preclinical data from Phase 3 study of Bria-IMT
2M ago
BCTX
BriaCell Therapeutics Closes $13.8 Million Public Offering
PremiumCompany Announcements
BriaCell Therapeutics Closes $13.8 Million Public Offering
2M ago
BCTX
BriaCell’s Breakthrough in Cancer Immunotherapy at AACR 2025
PremiumCompany Announcements
BriaCell’s Breakthrough in Cancer Immunotherapy at AACR 2025
2M ago
BCTX
BriaCell presents data from Phase 2 study of Bria-IMT
PremiumThe FlyBriaCell presents data from Phase 2 study of Bria-IMT
2M ago
BCTX
BriaCell 3.07M share Secondary priced at $4.50
Premium
The Fly
BriaCell 3.07M share Secondary priced at $4.50
2M ago
BCTX
BriaCell Therapeutics Announces $13.8 Million Public Offering
Premium
Company Announcements
BriaCell Therapeutics Announces $13.8 Million Public Offering
2M ago
BCTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >